Endpoints News· @endpts · X·· 25 天前精选AI 评分72
AI 导读
百时美施贵宝旗下一项自体免疫CAR-T试验中,一名多发性硬化患者死亡。公司同时表示,已查明另一项CAR-T试验在6月出现安全信号的原因。
推荐理由
百时美施贵宝披露其自体免疫CAR-T试验中一例多发性硬化患者死亡,并说明另一项试验6月安全信号的原因。
正文
A multiple sclerosis patient has died in a Bristol Myers autoimmune CAR-T trial. The company also says it now knows what caused June’s safety signal in a different CAR-T trial. https://endpoints.news/bristol-myers-reveals-autoimmune-car-t-trial-death-explains-summertime-pause/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
来源:Endpoints News · x.com